Vertex hepatitis C drug helps the hard-to-treat
Tuesday, September 7th, 2010Vertex Pharmaceuticals Inc. said Tuesday that a late-stage clinical trial showed its hepatitis C drug candidate telaprevir proved effective for patients who hadn’t been helped by other treatments.